A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma-Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG)

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 4, 2007, Pages 1187-1192

  Eich, Hans Theodor ^a   Gossmann, Axel ^a   Engert, Andreas ^a   Kriz, Jan ^a   Bredenfeld, Henning ^a   Hansemann, Katja ^a   Skripnitchenko, Roman ^a   Brillant, Corinne ^a   Pfistner, Beate ^a   Staar, Susanne ^b   Diehl, Volker ^a   Müller, Rolf Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b KLINIKUM BREMEN MITTE   (Germany)

Author keywords

Consolidative radiotherapy; Hodgkin's lymphoma; Panel; Quality assurance

Indexed keywords

CHEMOTHERAPY; DISEASES; QUALITY ASSURANCE; RADIOTHERAPY;

INTENSIVE CHEMOTHERAPY; INTERIM ANALYSIS; LYMPHOMA ANALYSIS; RESIDUAL DISEASE;

ONCOLOGY;

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DOSE ESCALATION; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM MASS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HODGKIN DISEASE; HUMANS; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM, RESIDUAL; PREDNISONE; PROCARBAZINE; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 35448952664     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.035     Document Type: Article

References (19)

1. Yung L., and Linch D. Hodgkin's lymphoma. Lancet 361 (2003) 943-951
2. Canellos G.P., Anderson J.R., Propert K.J., et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327 (1992) 1478-1484
3. Diehl V., Sieber M., Rüffer U., et al. BEACOPP, a new intensified chemotherapy regimen in advanced Hodgkin's disease. Ann Oncol 8 (1997) 143-148
4. Diehl V., Tesch H., Lathan B., et al. BEACOPP, a new intensified hybrid regimen, is at least equally effective compared with COPP/ABVD in patients with advanced stage Hodgkin's disease. Proc Am Soc Oncol 16 (1997) 2a
5. Diehl V., Franklin J., Pfreundschuh M., et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348 (2003) 2386-2395
6. Horning S., Hoppe R., Breslin S., et al. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol 20 (2002) 630-637
7. Loeffler M., Brosteanu O., Hasenclever D., et al. Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. J Clin Oncol 16 (1998) 818-829
8. Aleman B.M.P., Raemaekers J., Tirelli U., et al. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 348 (2003) 2396-2406
9. Eich H.T., Staar S., Gossmann A., et al. The HD12 Panel of the German Hodgkin Lymphoma Study Group (GHSG)-a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging. Am J Clin Oncol 27 (2004) 279-284
10. Carbone P.P., Kaplan H.S., Musshoff K., et al. Report of the committee of Hodgkin's disease staging classification. Cancer Res 31 (1971) 1860-1861
11. Lister T.A., Crowther D., Sutcliffe S.B., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease. Cotswolds Meeting. J Clin Oncol 7 (1989) 1630-1636
12. Eich H.T., Müller R.-P., Schneeweiss A., et al. Initiation of a teleradiotherapeutic network for patients in German lymphoma studies. Int J Radiat Oncol Biol Phys 58 (2004) 805-808
13. Bundesärztekammer. Leitlinien der Bundesärztekammer zur Qualitätssicherung in der Computertomographie. Dt Ärztebl 89 (1992) 3-11
14. Bundesausschuss der Ärzte und Krankenkassen. Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über Kriterien zur Qualitätsbeurteilung in der radiologischen Diagnostik gemäss § 136 SGB V in der Fassung vom 17. 6. 1992, zuletzt geändert am 17.12.1996. Dt Ärztebl 94 (1997) 581-588
15. Longo D., Young R., Wesles M., et al. Twenty years of MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 4 (1986) 1295-1306
16. van Leeuwen F., Klokman W., Veer M., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18 (2000) 487-497
17. Eich H.T., Staar S., Gossmann A., et al. Centralized radiation oncological review of cross-sectional imaging of Hodgkin's disease leads to significant changes of the required involved field-results of a quality assurance program of the German Hodgkin Study Group (GHSG). Int J Radiat Oncol Biol Phys 58 (2004) 1121-1127
18. Dühmke E., Franklin J., Pfreundschuh M., et al. Low-dose radiation is sufficient for the noninvolved extended field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 19 (2001) 2905-2914
19. Aleman B.M.P., Girinsky T., van Der Maazen R.W.M., et al. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884). Int J Radiat Oncol Biol Phys 63 (2005) 1184-1190